MedPath

e-GOLIAH in Autistic Spectrum Disorders

Not Applicable
Not yet recruiting
Conditions
Autism Spectrum Disorder
Interventions
Device: "e-GOLIAH"
Behavioral: Usual care
Registration Number
NCT05271955
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Brief Summary

Randomized open-label study comparing children aged 3 to 6 years with autism and normal cognitive development or mild cognitive impairment receiving the usual treatment plus intensive use of eGOLIAH (experimental group) with children receiving only the usual treatment (control group).

eGOLIAH (Gaming Open Library for Intervention in Autism at Home) is an accessible online platform for digital games inspired by the principles of the Early Start Denver Model (ESDM), one of the care programs validated in the management of young ASD.

The duration per patient will be one year. The exposure to e-GOLIAH for the experimental group will be done with the recommendation of intensive exposure to the game (5 sessions\> ½ hour per week).

Clinical variables will be assessed at entry, 6 months and 1 year (end of study).

The EQ5D questionnaires will be collected by the supervising therapist during the follow-up visit and at the same time as the clinical variables.

Detailed Description

In a context of increasing prevalence of Autism Spectrum Disorder (ASD) and the heterogeneity of children's profiles and abilities, early diagnosis is crucial in order to implement intensive, individualized, multidimensional therapeutic care and therefore more efficient. In the context of MICHELANGELO (FP7 European Research project), we developed a serious game called GOLIAH for Gaming Open Library for Intervention for Autism at Home. Using the first beta version as functional prototype, we showed that the demonstrator could be used at home with the help of parents in addition to usual care, during a clinical study including 25 participants. Also, Billeci and colleagues showed that, after training, children's improvement in joint attention tasks was correlated with changes in brain activity and connectivity. We then developed a new version e-GOLIAH to open the opportunity to conduct a large clinical study to assess the validity of the tool in terms of children's improvements. The goals of e-GOLIAH are to bring improvements in terms of ergonomics and accessibility to this initial prototype by finalizing the tool and distributing it to therapists, parents and children with ASD, via the Curapy.com web platform. e-GOLIAH provides, in free and open access, a platform for digital games inspired by the principles of ESDM (Early Start Denver Model) allowing intensive training to improve joint attention and imitation, two key skills for early social interaction and communication. It is a more natural, child-centered intervention method practiced at home and involving parents. This innovative solution takes the assessment and management of autism care out of the usual clinical environment. eGOLIAH (Gaming Open Library for Intervention in Autism at Home) is an accessible online platform for digital games that include ten different games with different level of complexity. A key principle is the collaboration between the child and his/her parent to proceed with the games making it interactive by nature, each participant having his own tablet.

The current study e-GOLIAH-ECO is a medico-economic study powered to recruit 150 children. It is a multisite randomized open-label study comparing children aged 3 to 6 years with autism and normal cognitive development or mild cognitive impairment receiving the usual treatment plus intensive use of eGOLIAH (experimental group) with children receiving only the usual treatment (control group).

The duration per patient will be one year. The exposure to e-GOLIAH for the experimental group will be done with the recommendation of intensive exposure to the game (5 sessions\> ½ hour per week).

Clinical variables will be assessed at entry, 6 months and 1 year (end of study). The EQ5D (quality of life) questionnaires will be collected by the supervising therapist during the follow-up visit and at the same time as the clinical variables.

The main objective is to evaluate the 12-month cost-effectiveness of the management of children diagnosed with ASDs using the e-GOLIAH game used at home, compared to usual management.

Secondary objective includes:

(i) To evaluate the cost-effectiveness ratio of the management of patients with ASDs using e-GOLIAH compared to usual management at 12 months of follow-up.

(ii) To explore the remaining ASD-related annual burden of the cost of disease for the two groups studied.

(iii) To evaluate the consequences of the generalization of the management of children diagnosed with ASD using e-GOLIAH, compared to a usual management, from the point of view of the Health Insurance over a period of 3 years.

(iv) To evaluate the impact of the management of children diagnosed with ASD using the e-GOLIAH game used at home, compared to usual management, on the patient's quality of life and that of their responsible parent and the correlation between the two, on adaptive symptoms, on autistic symptoms, on social interactions, on parental stress, at 6 months and at 12 months.

(v) To assess compliance with OS by children and their caregivers. The following scales will be monitored: the EQ5D-3L for quality of life, the Vineland-II scale, the Child Autism Rating Scale (CARS), the Social Responsiveness Scale (SRS), the Parenting Stress Index. In addition the medico-economic data will be monitored from regular interview and social insurance data.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
150
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Experimental"e-GOLIAH"Children receiving the usual care plus intensive use of e-GOLIAH (experimental group)
ControlUsual careChildren receiving only the usual treatment (control group).
Primary Outcome Measures
NameTimeMethod
Comparison of Incremental Cost-Utility Ratio (ICUR) at 12 months between the 2 groups12 months

ICUR use the 5-level EQ-5D version and the child-friendly EQ-5D version (EQ5D-5L/EQ5D-Y) questionnaires (min score : 0 ; max score : 100 ; higher scores mean a better outcome)

Secondary Outcome Measures
NameTimeMethod
Comparison of Incremental Cost-utility ratio (ICUR) at 6 months between the 2 groups6 months

ICUR use the 5-level EQ-5D version and the child-friendly EQ-5D version (EQ5D-5L/EQ5D-Y) questionnaires (min score : 0 ; max score : 100 ; higher scores mean a better outcome)

Comparison of Quality of life between the 2 groups6 and 12 months

Measured by the 5-level EQ-5D version and the child-friendly EQ-5D version measured by proxy EQ-5D-5L/EQ-5D-Y(proxy) for the patient and their parent. Scale 0-100 (min score: 0, max score :100, higher scores mean a better outcome)

Comparison of Autistic symptoms between the 2 groups6 and 12 months

Use the CARS (Child Autism Rating Ladder) scale, 15 items coded from 1 to 4 (score min: 0, max : 60, higher scores mean a worse outcome)

Comparison of the out of pocket payment for the consumption of treatments linked to the TSA between the 2 groups12 months

Amount remaining payable by the patient after deduction of reimbursements received by health insurance

The child's acceptability to the e-GOLIAH game at home6 and 12 months

interview with clinical team by phone contact every twice a month for 12 months

Comparison of Social interactions between the 2 groups6 and 12 months

Use the SRS (Social Responsiveness Scale) scale, 65 items coded from 1 to 4 (score min: 0 ; score max : 260, higher scores mean a worse outcome)

Comparison of Incremental cost-effectiveness ratio (ICER) between the 2 groups6 and 12 months

ICER use the Vineland II scale (undetermined minimum and maximum)composite score, average score : 100, higher scores mean a better outcome)

Budget impact analysis (BIA) of e-GOLIAH in the management of children diagnosed with TSA for health insurance3 years

Budget impact analysis (BIA) will be measured by direct resources consumed and quantified using the SNIIRAM/SNDS database

Comparison of Adaptive symptoms between the 2 groups6 and 12 months

Use the Vineland-II Scale of socio-adaptive behavior measured by the composite score with an average to 100 of 4 dimensions: socialization, communication, life skills everyday life, and motricity (undetermined minimum and maximum composite score, average score : 100, higher scores mean a better outcome)

Comparison of Parental Stress between the 2 groups6 and 12 months

Use the Parental Stress Index scale, 36 items coded from 1 to 5 (score min : 0 ; max: 180, higher scores mean a worse outcome)

Trial Locations

Locations (12)

Centre Hospitalier Universitaire de Strasbourg

🇫🇷

Strasbourg, Bas-Rhin, France

Centre Hospitalier Universitaire de Tours

🇫🇷

Tours, Indre-et-Loire, France

Centre Hospitalier Universitaire de Nancy

🇫🇷

Nancy, Meurthe-et-Moselle, France

Fondation Lenval - Hôpitaux Pédiatriques de Nice- CHU Lenval

🇫🇷

Nice, Alpes Maritimes, France

Centre Hospitalier Universitaire de Toulouse

🇫🇷

Toulouse, Haut-Garonne, France

Centre Hospitalier Universitaire de Montpellier

🇫🇷

Montpellier, Hérault, France

Assistance Publique - Hôpitaux de Paris, Site de la Pitié-Salpêtrière

🇫🇷

Paris, Ile De France, France

Assistance Publique - Hôpitaux de Paris, Site de Necker

🇫🇷

Paris, Ile De France, France

Centre Hospitalier Sainte-Anne / GHU Paris Psychiatrie et Neurosciences

🇫🇷

Paris, Ile De France, France

Centre Hospitalier de Versailles - André Mignot

🇫🇷

Versailles, Ile De France, France

Centre Hospitalier d'Amiens

🇫🇷

Amiens, Somme, France

Centre Hospitalier Universitaire de Paris - Centre Hospitalier d'Henri Laborit

🇫🇷

Poitiers, Vienne, France

© Copyright 2025. All Rights Reserved by MedPath